F Fruzzetti1, A Cagnacci2, F Primiero3, V De Leo4, C Bastianelli5, V Bruni6, S Caruso7, C Di Carlo8, M Farris9, G Grandi10, A Grasso10, M Guida11, M Meriggiola12, A M Paoletti13, A Cianci7, C Nappi11, A Volpe10. 1. Department of Obstetrics and Gynecology, University of Pisa, Pisa, Italy. 2. Department of Obstetrics and Gynecology, University of Genova, Genova, Italy. 3. Sapienza, University of Rome, Rome, Italy. 4. Department of Obstetrics and Gynecology, University of Siena, Siena, Italy. 5. Department of Gynecology, Obstetrics and Urology, Sapienza, University of Rome, Rome, Italy. 6. Department of Obstetrics and Gynecology, University of Florence, Florence, Italy. 7. Obstetrics and Gynecology Unit, Department of General Surgery and Medical Surgical Specialties, University of Catania, Catania, Italy. 8. Department of Obstetrics and Gynecology, "Magna Grecia" University, Catanzaro, Italy. 9. Sapienza, University of Rome & Italian Association for Demographic Education, Rome, Italy. 10. Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Modena, Italy. 11. Gynecology and Obstetrics Unit, Department of Neuroscience, Reproductive Sciences and Dentistry, University of Napoli Federico II, Napoli, Italy. 12. Department of Obstetrics and Gynecology, University of Bologna, Bologna, Italy. 13. Department of Surgical Sciences, Department of Obstetrics and Gynecology, University of Cagliari, Cagliari, Italy.
Abstract
Purpose: The Italian Society of Contraception identified as one of its priorities the need to give recommendations on management of contraception during Coronavirus-Covid 19 pandemiaMaterials and methods: A concise communication was produced which summarises in an easy-to-read format suitable for clinicians the management of the different contraceptives mostly used. Information how to manage contraception in different conditions is presented. Results: Women may, in general, continue to use either intrauterine and or hormonal contraceptives. The use of condom should be added to any hormonal contraceptive, when the contraceptive efficacy is reduced or when women stop the contraceptive method. Conclusion: At the present time, during the Coronavirus-Covid 19 pandemia, no data contraindicate the use of intrauterine or hormonal contraceptives. Conversely the use of an appropriate contraception is advocate to prevent unintended pregnancies.
Purpose: The Italian Society of Contraception identified as one of its priorities the need to give recommendations on management of contraception during Coronavirus-Covid 19 pandemiaMaterials and methods: A concise communication was produced which summarises in an easy-to-read format suitable for clinicians the management of the different contraceptives mostly used. Information how to manage contraception in different conditions is presented. Results:Women may, in general, continue to use either intrauterine and or hormonal contraceptives. The use of condom should be added to any hormonal contraceptive, when the contraceptive efficacy is reduced or when women stop the contraceptive method. Conclusion: At the present time, during the Coronavirus-Covid 19 pandemia, no data contraindicate the use of intrauterine or hormonal contraceptives. Conversely the use of an appropriate contraception is advocate to prevent unintended pregnancies.
Authors: Corinne LaVasseur; Suvi Neukam; Thomas Kartika; Bethany Samuelson Bannow; Joseph Shatzel; Thomas G DeLoughery Journal: Res Pract Thromb Haemost Date: 2022-08-23
Authors: Iñaki Lete; Jesus Novalbos; Esther de la Viuda; Felix Lugo; Mercedes Herrero; Marian Obiol; Josep Perelló; Rafael Sanchez-Borrego Journal: Open Access J Contracept Date: 2021-05-20